US Edition
Australia Approves First Koala Chlamydia Vaccine for Field Use
The single-dose vaccine reduces koala mortality from chlamydia by at least 65%, providing a practical solution without booster shots after over a decade of research.
- Australia has approved the first koala chlamydia vaccine for nationwide use, developed by the University of the Sunshine Coast after over 10 years of research.
- The single-dose vaccine can be used in wildlife hospitals, veterinary clinics, and field settings to protect endangered koalas from a disease causing infertility and death.
- Professor Peter Timms stated that the vaccine could reduce symptoms of chlamydia during breeding age and decrease mortality among wild koalas by at least 65%.
- The Australian government committed A$76 million to support the vaccine's rollout and ongoing conservation efforts for koalas.
190 Articles
190 Articles
Australia approves world's first chlamydia vaccine for koalas
(NewsNation) — A first-of-its-kind chlamydia vaccine has hit the market, and it's not for humans. Australian researchers developed the vaccine for koalas, which are at risk of infertility and death due to widespread chlamydia infections. The disease accounts for nearly half of wild koala deaths in Australia, according to lead researcher Peter Timms. “We knew a single-dose vaccine — with no need for a booster — was the answer to reducing the rapi…
Koala Chlamydia Vaccine Receives Australian Tick of Approval
The Australian federal government has approved a historic single-dose vaccine to protect koalas from chlamydia, a disease threatening the survival of the species. Chlamydia can cause painful infections, infertility, blindness, and death in koalas. Infection rates in some populations reach up to 70 percent, with the bacterial disease threatening the survival of koalas in eastern Australia. The vaccine was developed by researchers at the Universit…
Thanks to regulatory approval, the vaccine can be used in wildlife hospitals, veterinarians and conservation.
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
